Loading... Please wait.
Company profile
VALBIOTIS is a French Research & Development company committed to scientific innovation for the prevention and control of metabolic diseases. VALBIOTIS specializes in the development of innovative nutritional solutions for cardio-metabolic disease prevention and nutritional support for patients. The products are intended for food and pharmaceutical industries. VALBIOTIS is essentially intervening in the prevention of type 2 diabetes, NASH (non-alcoholic steatohepatitis), obesity and cardiovascular diseases.
VALBIOTIS has established numerous partnerships with academic centers of excellence in France and overseas, including the University of La Rochelle, the CNRS, and the Clermont Auvergne University in Clermont-Ferrand where the company has opened a secondary school. With these agreements, since its inception VALBIOTIS has benefited from a strong leverage thanks notably to experts and technical partners involved in its projects.
Source:
Cofisem
-
Last Update:
11 Mar 2025
Key Executives
| Chairman of the Management Board | Sébastien Peltier | ||||
| Member of the Management Board | Sébastien Bessy | ||||
| Chief Operating Officer | Sébastien Bessy | ||||
| Member of the Management Board | Murielle Cazaubiel | ||||
| Member of the Management Board | Pascal Sirvent | ||||
| Chief Financial Officer | Stanislas Sordet | ||||
| Head of Investor Relations | Charlotte Jezequel | ||||
| Chief Human Resources Officer | Charlotte Jezequel | ||||
| Source: Cofisem - Last Update: 11 Mar 2025 | |||||
Key figures
| Millenium | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Net sales | 4.733 | 785 | 298 | 3.092 | 91 |
| Income from ordinary activities | 6.761 | 2.677 | 2.048 | 4.350 | 1.913 |
| Operating income | -7.180 | -12.026 | -8.475 | -3.407 | -5.157 |
| Cost of financial indebtedness net | 188 | 288 | 229 | 422 | 358 |
| Equity-accounted companies contribution to income | |||||
| Net profit from discontinued activities | |||||
| Net income | -7.368 | -12.312 | -8.681 | -3.829 | -5.504 |
| Net income (Group share) | -7.368 | -12.312 | -8.681 | -3.829 | -5.504 |
| Fiscal year end | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
| Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
| Account Standards | IFRS | IFRS | IFRS | IFRS | IFRS |
| Source: Cofisem - Last Update: 11 Mar 2025 | |||||
Shareholder information
Address
VALBIOTIS
Zone des Quatre Chevaliers 4 Avenue Éric Tabarly
FR-17180
Périgny
France
Phone number:
+33 (0)5 46 28 62 58
Source:
Cofisem
-
Last Update:
11 Mar 2025